Last reviewed · How we verify

NCT02803489

Evaluation of the Performance of an e-Health System

Terminated NA Last updated 11 September 2025
What this trial tests

NA trial testing medical device intervention in Chronic Diseases in 23 participants. Terminated before completion.

Timeline
8 April 2016
Primary endpoint
23 March 2017
9 May 2017

Quick facts

Lead sponsorAir Liquide Santé International
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment23
Start date8 April 2016
Primary completion23 March 2017
Estimated completion9 May 2017
Sites6 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Air Liquide Santé International — full company profile →

Who can join

18 and older, any sex, with Chronic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective, non-randomized, open-label, pilot study conducted in a single group of 30 evaluable patients, i.e. patients completing an approximate 3 month follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S, Carter D, Threapleton CJ, Prigmore S, et al · · 2021 · cited 70× · PMID 34693988 · DOI 10.1002/14651858.cd013196.pub2

Verify or expand the search:

Other recruiting trials for Chronic Diseases

Currently open trials in the same condition.

Other Air Liquide Santé International trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02803489.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing